| 2026 |
|
| Seznam cyklů EHK Klepněte na kód cyklu jehož vyhodnocení si chcete prohlédnout. |
List of EQA rounds Click a code of the round to access the evaluation. |
| Kód cyklu EHK Code of EQA round |
Stop termín Deadline |
Název programu EHK Name of EQA programme |
| ABR1/26 | 13.2.2026 | Parametry acidobazické rovnováhy Acid-base Status and Electrolytes |
| ABR2/26 | 24.7.2026 | |
| ABR3/26 | 13.11.2026 | |
| AIH1/26 | 6.3.2026 | Autoimunitní hepatopatie Autoimmune Liver Diseases |
| AIH2/26 | 16.10.2026 | |
| AIM11/26 | 13.3.2026 | Autoimunita 1 Autoimmunity 1 |
| AIM12/26 | 25.9.2026 | |
| AIM21/26 | 10.4.2026 | Autoimunita 2 Autoimmunity 2 |
| AIM22/26 | 23.10.2026 | |
| AKS1/26 | 23.1.2026 | Analyty krevního séra Basic Clinical Chemistry - Serum |
| AKS2/26 | 3.4.2026 | |
| AKS3/26 | 24.7.2026 | |
| AKS4/26 | 2.10.2026 | |
| ALB1/26 | 3.4.2026 | Stanovení albuminu v moči Albumin in Urine |
| ALB2/26 | 2.10.2026 | |
| AM1/26 | 3.4.2026 | Analyty moče Basic Clinical Chemistry - Urine |
| AM2/26 | 2.10.2026 | |
| AP1/26 | 27.3.2026 | Antitrombotické přípravky Antithrombotic Agents |
| AP2/26 | 18.9.2026 | |
| APLA1/26 | 13.3.2026 | Antifosfolipidové protilátky Antiphospholipid Antibodies |
| APLA2/26 | 25.9.2026 | |
| AT1/26 | 10.4.2026 | Autoprotilátky u tyreopatií Autoantibodies in Thyroid Diseases |
| AT2/26 | 23.10.2026 | |
| BIL1/26 | 20.3.2026 | Bilirubin novorozenecký Bilirubin Neonatal |
| BIL2/26 | 21.8.2026 | |
| BM1/26 | 10.4.2026 | Kostní markery Bone Markers |
| BM2/26 | 23.10.2026 | |
| CC1/26 | 20.3.2026 | Cystatin C Cystatin C |
| CC2/26 | 21.8.2026 | |
| CD341/26 | 4.5.2026 | Stanovení populace buněk CD34+ Population of CD34+ Cells |
| CD342/26 | 2.11.2026 | |
| CRC1/26 | 27.4.2026 | Kolorektální karcinom Colorectal Carcinoma |
| CRC2/26 | 22.9.2026 | |
| CRP1/26 | 20.3.2026 | Stanovení CRP C-Reactive Protein |
| CRP2/26 | 1.5.2026 | |
| CRP3/26 | 21.8.2026 | |
| CRP4/26 | 20.11.2026 | |
| CRPP1/26 | 23.1.2026 | Stanovení CRP systémy POCT C-Reactive Protein POCT |
| CRPP2/26 | 27.2.2026 | |
| CRPP3/26 | 5.6.2026 | |
| CRPP4/26 | 4.9.2026 | |
| CRPP5/26 | 23.10.2026 | |
| CRPP6/26 | 4.12.2026 | |
| CSFB1/26 | 13.2.2026 | Biochemická analýza likvoru Cerebrospinal Fluid Analysis |
| CSFB2/26 | 11.9.2026 | |
| CSFC1/26 | 13.2.2026 | Cytologie likvoru Cerebrospinal Fluid Cytology |
| CSFC2/26 | 11.9.2026 | |
| CSFF1/26 | 13.2.2026 | Izoelektrická fokusace likvoru Isoelectric Focusing of CSF |
| CSFF2/26 | 11.9.2026 | |
| CSFK1/26 | 13.2.2026 | Klinická analýza likvoru Cerebrospinal Fluid Diagnostics |
| CSFK2/26 | 11.9.2026 | |
| CSH1/26 | 22.5.2026 | Cytochemické barvení v hematologii Cytochemical Staining in Haematology |
| CSH2/26 | 30.10.2026 | |
| DD1/26 | 27.3.2026 | D Dimery D Dimers |
| DD2/26 | 12.6.2026 | |
| DD3/26 | 18.9.2026 | |
| DD4/26 | 27.11.2026 | |
| DGP1/26 | 30.1.2026 | Analýza moče testovacími proužky Urine Strip Tests Analysis |
| DGP2/26 | 1.5.2026 | |
| DGP3/26 | 13.11.2026 | |
| DIF1/26 | 13.3.2026 | Hodnocení nátěru periferní krve Peripheral Blood Morphology Evaluation |
| DIF2/26 | 22.5.2026 | |
| DIF3/26 | 18.9.2026 | |
| DIF4/26 | 30.10.2026 | |
| E11/26 | 6.2.2026 | Endokrinologie 1 Hormones 1 |
| E12/26 | 24.4.2026 | |
| E13/26 | 17.7.2026 | |
| E14/26 | 9.10.2026 | |
| E21/26 | 6.2.2026 | Endokrinologie 2 Hormones 2 |
| E22/26 | 24.4.2026 | |
| E23/26 | 17.7.2026 | |
| E24/26 | 9.10.2026 | |
| FC1/26 | 27.2.2026 | Kalprotektin ve stolici Calprotectin in Stool |
| FC2/26 | 28.8.2026 | |
| FOB1/26 | 1.5.2026 | Okultní krvácení Faecal Occult Blood |
| FOB2/26 | 20.11.2026 | |
| GHP1/26 | 27.2.2026 | Glykovaný hemoglobin POCT Glycated Haemoglobin POCT |
| GHP2/26 | 23.10.2026 | |
| GLC1/26 | 21.4.2026 | Stanovení glukózy (včetně glukometrů) Glucose (Including Glucometers) |
| GLC2/26 | 3.11.2026 | |
| GP1/26 | 27.2.2026 | Gamapatie Detection of Monoclonal Components |
| GP2/26 | 28.8.2026 | |
| HCB1/26 | 22.5.2026 | Histologické a cytologické barvení Histological and Cytological Staining |
| HCB2/26 | 4.12.2026 | |
| HIL1/26 | 17.4.2026 | Sérové indexy Serum Indices |
| HIL2/26 | 30.10.2026 | |
| HKG1/26 | 27.3.2026 | Hemokoagulace Haemocoagulation Tests |
| HKG2/26 | 12.6.2026 | |
| HKG3/26 | 18.9.2026 | |
| HKG4/26 | 27.11.2026 | |
| HR1/26 | 20.2.2026 | Hormonální receptory Hormonal Receptors |
| HR2/26 | 4.9.2026 | |
| HS1/26 | 12.6.2026 | Hemokoagulace speciální Haemocoagulation Special |
| HS2/26 | 27.11.2026 | |
| IDDM1/26 | 6.3.2026 | Autoimunitní diabetes 1. typu Type 1 Autoimmune Diabetes |
| IDDM2/26 | 16.10.2026 | |
| IFT1/26 | 4.5.2026 | Imunofenotypizace Immunophenotypisation |
| IFT2/26 | 2.11.2026 | |
| IGIT1/26 | 6.3.2026 | Imunopatologie GIT Immunopathology of GIT |
| IGIT2/26 | 16.10.2026 | |
| IH1/26 | 6.3.2026 | Imunohematologie Blood Group Serology |
| IH2/26 | 29.5.2026 | |
| IH3/26 | 2.10.2026 | |
| IH4/26 | 13.11.2026 | |
| IHC1/26 | 20.2.2026 | Imunohistochemie - detekce HER-2/neu Immunohistochemistry - Detection of HER-2/neu |
| IHC2/26 | 4.9.2026 | |
| INRP1/26 | 27.2.2026 | Měření INR systémy POCT INR measurement on POCT |
| INRP2/26 | 5.6.2026 | |
| INRP3/26 | 4.9.2026 | |
| INRP4/26 | 23.10.2026 | |
| KD1/26 | 23.1.2026 | Glykovaný hemoglobin Glycated Haemoglobin |
| KD2/26 | 3.4.2026 | |
| KD3/26 | 24.7.2026 | |
| KD4/26 | 30.10.2026 | |
| KM1/26 | 20.3.2026 | Kardiální markery Cardiac Markers |
| KM2/26 | 21.8.2026 | |
| KO1/26 | 6.3.2026 | Krevní obraz Blood Count |
| KO2/26 | 17.4.2026 | |
| KO3/26 | 15.5.2026 | |
| KO4/26 | 19.6.2026 | |
| KO5/26 | 11.9.2026 | |
| KO6/26 | 25.9.2026 | |
| KO7/26 | 9.10.2026 | |
| KO8/26 | 23.10.2026 | |
| LMWH1/26 | 27.3.2026 | Nízkomolekulární heparin Low Molecular Weight Heparin |
| LMWH2/26 | 18.9.2026 | |
| MS1/26 | 30.1.2026 | Močový sediment Urinary Sediment Morphology |
| MS2/26 | 1.5.2026 | |
| MS3/26 | 13.11.2026 | |
| NF1/26 | 13.3.2026 | Nátěr periferní krve - fotografie Peripheral Blood Smears - Photos |
| NF2/26 | 18.9.2026 | |
| NKDF1/26 | 1.5.2026 | Nátěr kostní dřeně - fotografie Bone Marrow Aspirate Film |
| NKDF2/26 | 25.9.2026 | |
| PAT1/26 | 29.5.2026 | Přímý antiglobulinový test Direct Antiglobulin Test |
| PAT2/26 | 13.11.2026 | |
| PDL11/26 | 9.6.2026 | Programmed Death Ligand 1 Programmed Death Ligand 1 |
| PDL12/26 | 10.11.2026 | |
| PIG1/26 | 6.3.2026 | Podtřídy IgG IgG subclasses |
| PIG2/26 | 16.10.2026 | |
| PRO1/26 | 27.2.2026 | Proteiny v krevním séru Specific Proteins |
| PRO2/26 | 28.8.2026 | |
| RET1/26 | 24.4.2026 | Retikulocyty Reticulocytes |
| RET2/26 | 18.9.2026 | |
| RF1/26 | 13.3.2026 | Diagnostika revmatoidní artritidy a ASLO Diagnostics of Rheumatoid Arthritis and ASLO |
| RF2/26 | 25.9.2026 | |
| RFA1/26 | 3.4.2026 | Rizikové faktory aterosklerózy Risk Factors for Atherosclerosis |
| RFA2/26 | 2.10.2026 | |
| SED1/26 | 27.3.2026 | Sedimentační rychlost erytrocytů Erythrocyte Sedimentation Rate |
| SED2/26 | 18.9.2026 | |
| TDM1/26 | 24.4.2026 | Léky Therapeutic Drugs |
| TDM2/26 | 9.10.2026 | |
| TE1/26 | 3.3.2026 | Stanovení stopových prvků Trace Elements |
| TE2/26 | 1.9.2026 | |
| TIE1/26 | 27.2.2026 | Stanovení celkového IgE Allergy Control Scheme (Total IgE) |
| TIE2/26 | 28.8.2026 | |
| TM1/26 | 10.2.2026 | Tumorové markery Tumour Markers |
| TM2/26 | 28.4.2026 | |
| TM3/26 | 21.7.2026 | |
| TM4/26 | 13.10.2026 | |
| VIB1/26 | 22.5.2026 | Všeobecná imunohistochemie - barvení General Immunohistochemistry - Staining |
| VIB2/26 | 4.12.2026 | |
| VVV1/26 | 17.4.2026 | Diagnostika vrozených vývojových vad Maternal Diagnostic Screening (Triple Test) |
| VVV2/26 | 30.10.2026 |